Community-acquired pneumonia

M Falguera; M F Ramírez

doi:10.1016/j.rce.2015.06.002

Community-acquired pneumonia

Rev Clin Esp (Barc). 2015 Nov;215(8):458-67. doi: 10.1016/j.rce.2015.06.002. Epub 2015 Jul 15.

[Article in English, Spanish]

Authors

M Falguera¹, M F Ramírez²

Affiliations

¹ Servicio de Medicina Interna, Hospital Universitari Arnau de Vilanova, Lleida, España. Electronic address: falguera@medicina.udl.cat.
² Servicio de Medicina Interna, Hospital Universitari Arnau de Vilanova, Lleida, España.

PMID: 26186969
DOI: 10.1016/j.rce.2015.06.002

Abstract

This article not only reviews the essential aspects of community-acquired pneumonia for daily clinical practice, but also highlights the controversial issues and provides the newest available information. Community-acquired pneumonia is considered in a broad sense, without excluding certain variants that, in recent years, a number of authors have managed to delineate, such as healthcare-associated pneumonia. The latter form is nothing more than the same disease that affects more frail patients, with a greater number of risk factors, both sharing an overall common approach.

Keywords: Biomarcadores; Biomarkers; Clinical manifestations; Community-acquired pneumonia; Diagnosis; Diagnóstico; Epidemiology; Epidemiología; Factores de riesgo; Manifestaciones clínicas; Neumonía adquirida en la comunidad; Prognosis; Pronóstico; Risk factors.